149 related articles for article (PubMed ID: 38270548)
21. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.
Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J
Lancet Psychiatry; 2021 Oct; 8(10):883-891. PubMed ID: 34474013
[TBL] [Abstract][Full Text] [Related]
22. Risk of breast cancer in risperidone users: A nationwide cohort study.
Reutfors J; Wingård L; Brandt L; Wang Y; Qiu H; Kieler H; Bahmanyar S
Schizophr Res; 2017 Apr; 182():98-103. PubMed ID: 27823949
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer and treatment with neuroleptics.
Thompson WD; Weissman MM
Arch Gen Psychiatry; 1979 May; 36(5):604-5. PubMed ID: 35119
[No Abstract] [Full Text] [Related]
24. Post-diagnostic antipsychotic use and cancer mortality: a population based cohort study.
Hicks BM; Busby J; Mills K; O'Neil FA; McIntosh SA; Zhang SD; Liberante FG; Cardwell CR
BMC Cancer; 2020 Aug; 20(1):804. PubMed ID: 32831062
[TBL] [Abstract][Full Text] [Related]
25. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
27. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Hummer M; Huber J
Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of neuroleptic drugs on the neuroendocrine system.
Meltzer HY
Adv Biochem Psychopharmacol; 1985; 40():59-68. PubMed ID: 2862768
[No Abstract] [Full Text] [Related]
29. Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects.
Halbreich U; Kinon BJ; Gilmore JA; Kahn LS
Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():53-67. PubMed ID: 12504072
[TBL] [Abstract][Full Text] [Related]
30. Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():69-82. PubMed ID: 12650682
[TBL] [Abstract][Full Text] [Related]
31. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.
Maguire GA
J Clin Psychiatry; 2002; 63 Suppl 4():56-62. PubMed ID: 11913677
[TBL] [Abstract][Full Text] [Related]
32. Delusions of pregnancy associated with increased prolactin concentrations produced by antipsychotic treatment.
Ali JA; Desai KD; Ali LJ
Int J Neuropsychopharmacol; 2003 Jun; 6(2):111-5. PubMed ID: 12890303
[TBL] [Abstract][Full Text] [Related]
33. Breast carcinoma in patients receiving neuroleptic therapy. Morphologic and clinicopathologic features of thirteen cases.
Tsubura A; Hatano T; Murata A; Shoji T; Shikata N; Morii S
Acta Pathol Jpn; 1992 Jul; 42(7):494-9. PubMed ID: 1357916
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?
O'Keane V; Meaney AM
J Clin Psychopharmacol; 2005 Feb; 25(1):26-31. PubMed ID: 15643097
[TBL] [Abstract][Full Text] [Related]
35. Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals.
Leung JCN; Ng DWY; Chu RYK; Chan EWW; Huang L; Lum DH; Chan EWY; Smith DJ; Wong ICK; Lai FTT
Epidemiol Psychiatr Sci; 2022 Sep; 31():e61. PubMed ID: 36059215
[TBL] [Abstract][Full Text] [Related]
36. Levels of prolactin and testosterone and associated sexual dysfunction and breast abnormalities in men with schizophrenia treated with antipsychotic medications.
Redman B; Kitchen C; Johnson KW; Bezwada P; Kelly DL
J Psychiatr Res; 2021 Nov; 143():50-53. PubMed ID: 34450525
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
[TBL] [Abstract][Full Text] [Related]
38. [Hyperprolactinemia in mentally ill patients].
Carvalho MM; Góis C
Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
[TBL] [Abstract][Full Text] [Related]
39. A real-world analysis of healthcare costs and relative risk of hyperprolactinemia associated with antipsychotic treatments in the United States.
Cloutier M; Greene M; Touya M; Gagnon-Sanschagrin P; Guerin A
J Med Econ; 2018 Dec; 21(12):1183-1190. PubMed ID: 30188234
[TBL] [Abstract][Full Text] [Related]
40. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.
Smith S; Wheeler MJ; Murray R; O'Keane V
J Clin Psychopharmacol; 2002 Apr; 22(2):109-14. PubMed ID: 11910254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
